Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 13:15:4517-4527.
doi: 10.2147/IDR.S375197. eCollection 2022.

Seasonal Malaria Chemoprevention Implementation: Effect on Malaria Incidence and Immunity in a Context of Expansion of P. falciparum Resistant Genotypes with Potential Reduction of the Effectiveness in Sub-Saharan Africa

Séni Nikiema  1   2 , Issiaka Soulama  1   3 , Salif Sombié  1 , André-Marie Tchouatieu  4 , Samuel Sindie Sermé  5 , Noëlie Béré Henry  5 , Nicolas Ouedraogo  1 , Nathalie Ouaré  1   6 , Raissa Ily  1   6 , Oumarou Ouédraogo  3 , Dramane Zongo  3 , Florencia Wendkuuni Djigma  2 , Alfred B Tiono  1 , Sodiomon B Sirima  5 , Jacques Simporé  2   7
Affiliations
Review

Seasonal Malaria Chemoprevention Implementation: Effect on Malaria Incidence and Immunity in a Context of Expansion of P. falciparum Resistant Genotypes with Potential Reduction of the Effectiveness in Sub-Saharan Africa

Séni Nikiema et al. Infect Drug Resist. .

Abstract

Seasonal Malaria Chemoprevention (SMC), which combines amodiaquine (AQ) with sulfadoxine-pyrimethamine (SP), is an effective and promising strategy, recommended by WHO, for controlling malaria morbidity and mortality in areas of intense seasonal transmission. Despite the effectiveness of this strategy, a number of controversies regarding the impact of the development of malaria-specific immunity and challenges of the strategy in the context of increasing and expanding antimalarial drugs resistance but also the limited coverage of the SMC in children make the relevance of the SMC questionable, especially in view of the financial and logistical investments. Indeed, the number of malaria cases in the target group, children under 5 years old, has increased while the implementation of SMC is been extended in several African countries. This ambivalence of the SMC strategy, the increase in the prevalence of malaria cases suggests the need to evaluate the SMC and understand some of the factors that may hinder the success of this strategy in the implementation areas. The present review discusses the impact of the SMC on malaria morbidity, parasite resistance to antimalarial drugs, molecular and the immunity affecting the incidence of malaria in children. This approach will contribute to improving the malaria control strategy in highly seasonal transmission areas where the SMC is implemented.

Keywords: amodiaquine; immunity; resistance; seasonal malaria chemoprevention; sulfadoxine-pyrimethamine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Paper mining flowchart. *Others West Africa include Gambia, Nigeria, Ghana, Côte D’Ivoire, Guinea, Chad, and Mauritania.
Figure 2
Figure 2
Three countries accounting for more than 80% of the SMC studies in West Africa.
Figure 3
Figure 3
Example of Seasonal Malaria Chemoprevention deployment and coverage in Burkina Faso (unpublished data from Malaria Consortium).
See this image and copyright information in PMC

References

    1. World Health Organization. World Malaria Report; 2021. ISBN978 92 4 004049 6.
    1. Ndiaye M, Sylla K, Sow D, et al. Potential impact of seasonal malaria chemoprevention on the acquisition of antibodies against glutamate-rich protein and apical membrane antigen 1 in children living in Southern Senegal. Am J Trop Med Hyg. 2015;93(4):798–800. doi:10.4269/ajtmh.14-0808 - DOI - PMC - PubMed
    1. World Health Organization. Seasonal Malaria Chemoprevention (SMC) for Plasmodium Falciparum Malaria Control in Highly Seasonal Transmission Areas of the Sahel Sub-Regions in Africa. Geneva, Switzerland: WHO Global Malaria Programme; 2012.
    1. Cairns M, Roca-Feltrer A, Garske T, et al. Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nat Commun. 2012;3:1–9. doi:10.1038/ncomms1879 - DOI - PMC - PubMed
    1. Grais RF, Laminou IM, Messe LW, et al. Molecular markers of resistance to amodiaquine plus sulfadoxine – pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger. Malar J. 2018;17:1–9. doi:10.1186/s12936-018-2242-4 - DOI - PMC - PubMed

LinkOut - more resources